Kite Pharma Asks FDA to Pave Way Toward It Holding Clinical Trials of Its Myeloma Therapy KITE-585 – Myeloma Research News
Myeloma Research News |
Kite Pharma Asks FDA to Pave Way Toward It Holding Clinical Trials of Its Myeloma Therapy KITE-585
Myeloma Research News Because the protein is crucial to myeloma cells' survival and growth, it is a good target for chimeric antigen receptor T-cell treatments, also known as CAR T-cell therapies. Those therapies use a patient's own immune cells to combat their disease. The … Kite Pharma, Inc. (NASDAQ:KITE) Traded 21.0% Above Its 50 Day Average Kite Pharma, Inc. (NASDAQ:KITE) Stock Closed Much Higher Than … Kite Pharma, Inc. (NASDAQ:KITE) Traded Significantly Above Its 50 … |
